Listen
Reason for request
Inclusion on the list of medicines reimbursed by National Insurance (packages of 5, 10 and 30 tablets) and approved for use by hospitals (packages of 5, 10, 30 and 100 tablets).
-
Clinical Benefit
| Substantial |
The actual benefit of XARELTO 10 mg tablets is substantial. |
Clinical Added Value
| minor |
XARELTO 10 mg tablets provides a minor improvement in actual benefit (IAB IV) in terms of efficacy compared with LOVENOX (enoxaparin) for the prevention of venous thromboembolism in adult patients undergoing elective hip or knee replacement surgery. |
English version
Contact Us
Évaluation des médicaments
